Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steps toward gene therapy: 1. The initial trials

R M Blaese1

  • 1Clinical Gene Therapy Branch, National Center for Human Genome Research, National Institutes of Health, Bethesda, Md., USA.

Hospital Practice (1995)
|November 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The treatment of adenosine deaminase deficiency.

Immunology today·2014
Same author

A novel approach using transcomplementing adenoviral vectors for gene therapy of adrenocortical cancer.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2002
Same author

Biosynthetic ganciclovir triphosphate: its isolation and characterization from ganciclovir-treated herpes simplex thymidine kinase-transduced murine cells.

Biochemical and biophysical research communications·2001
Same author

AV.TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor deposits.

Gene therapy·2001
Same author

Development of a skin-based metabolic sink for phenylalanine by overexpression of phenylalanine hydroxylase and GTP cyclohydrolase in primary human keratinocytes.

Gene therapy·2001
Same author

Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

Blood·2000
Same journal

A rocking biologic prosthetic valve: <i>Cutibacterium acnes</i> prosthetic valve endocarditis.

Hospital practice (1995)·2026
Same journal

Diagnostic accuracy of the Wells score versus duplex ultrasound for deep vein thrombosis in a Ghanaian cohort.

Hospital practice (1995)·2026
Same journal

Examining the frequency and factors related to the occurrence of deep vein thrombosis (DVT) in patients undergoing posterior fixation of the lumbosacral spine (PSF).

Hospital practice (1995)·2025
Same journal

The impact of hospitalist experience on patient outcomes: a retrospective cohort analysis at an academic medical center.

Hospital practice (1995)·2025
Same journal

The efficacy of melatonin as a preoperative anxiolytic in real-world setting: a randomized controlled trial.

Hospital practice (1995)·2025
Same journal

Antibiotic prescription patterns among hospitalized patients with influenza: a cross-sectional study in a tertiary referral hospital in Iran.

Hospital practice (1995)·2025
See all related articles

Gene therapy offers hope for genetic diseases, with cancer and AIDS trials expanding unexpectedly. Practical challenges remain, as seen in adenosine deaminase deficiency treatments.

Area of Science:

  • Biotechnology
  • Medical Genetics
  • Immunology

Background:

  • Gene therapy research is advancing for genetic disorders.
  • Early gene therapy focused on inherited immune deficiencies.
  • Cancer and AIDS are now major targets for gene therapy clinical trials.

Purpose of the Study:

  • To explore the current landscape of gene therapy applications.
  • To highlight the shift in focus from monogenic to acquired genetic diseases.
  • To discuss the practical challenges in developing gene therapies.

Main Methods:

  • Review of ongoing clinical trials in gene therapy.
  • Analysis of research trends in genetic disease treatment.
  • Case study of adenosine deaminase deficiency gene therapy.

Related Experiment Videos

Main Results:

  • Most current gene therapy clinical trials target cancer and AIDS.
  • Initial expectations for gene therapy focused on monogenic diseases were not fully met.
  • Adenosine deaminase deficiency treatment illustrates significant hurdles in practical gene therapy implementation.

Conclusions:

  • Gene therapy shows promise but faces considerable practical difficulties.
  • The application of gene therapy has evolved beyond initial expectations.
  • Further research is needed to overcome challenges in delivering effective gene therapies for complex diseases.